CMND Files European Patent for PTSD Psychedelic Compounds, Targets $18.5B Market, Aligns with Trump Psychedelic Order
Clearmind Medicine Inc. Common Shares · Now $3.17
-13% in 7d after detection
Post-detection moves
1h
—
1d
-8.4%
3d
-9.8%
7d
-13%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS